azacitidine,venetoclax
roche,abbvie
['leukemia', 'aza+', 'congrat']
#ash22: flamsa strikes back. more ct may not cr but can we id pts who might convert to (mrd-?) cr with a round of aza+ven+? outcomes still? that said, impressive lfs on both arms, and fewer hospital days = better hsct morbidity. congrats &amp; prof schetelig! 
Weill-Cornell hem/onc fellow; interested in clinical application of big data&machine learning in heme malig and HSCT; dad to 3 very silly kids